Maarten F. Bijlsma - Concepedia

Author

Maarten F. Bijlsma

Also Known As

Bijlsma, Maarten F, Bijlsma, Maarten F., Jeanin E van Hooft, M BIJLSMA, M. Bijlsma, M. F. Bijlsma, M.F. Bijlsma, Maarten Bijlsma, Maarten F Bijlsma, Maarten F. Bijlsma

312

Publications

8.9K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Amsterdam University Medical Centers Amsterdam UMC Location University of Amsterdam Oncode Institute Cancer Center Amsterdam

About

Maarten F. Bijlsma is an author at University of Amsterdam specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	23	3.5K
2	Cell Biology	17	17	3K
3	Health Sciences	5	5	327
4	Natural Sciences	2	2	181
5	Biology	1	1	100

Maarten F. Bijlsma

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway Wouter J. de Jonge, Esmerij P. van der Zanden, Frans Olivier The, Nature Immunology InflammationCytokineSignal TransductionSignaling PathwayJak2-stat3 Signaling Pathway	2005	1.1K
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions Felipe de Sousa e Melo, Xin Wang, Marnix Jansen, Nature Medicine Tumor BiologyMolecularly Distinct SubtypeGastrointestinal OncologyMedicinePoor-prognosis Colon Cancer	2013	765
Repression of Smoothened by Patched-Dependent (Pro-)Vitamin D3 Secretion Maarten F. Bijlsma, C. Arnold Spek, Danica Živković, PLoS Biology	2006	314
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT) Tom van den Ende, Nicolien C. de Clercq, Mark I. van Berge Henegouwen, Clinical Cancer Research	2021	267
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer Erica J. Childs, Evelina Mocci, Daniele Campa, Nature Genetics Pancreatic CancerMedicinePathologyCancer GenomicsCommon Variation	2015	265
Apc-mutant cells act as supercompetitors in intestinal tumour initiation Sanne M. van Neerven, Nina E. de Groot, Lisanne E. Nijman, Nature Apc-mutant Cells ActMedicineColorectal CancerCancer BiologyCell Biology	2021	197
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma Eva A. Ebbing, Amber P. van der Zalm, Anne Steins, Proceedings of the National Academy of Sciences Esophageal CancerImmunologyPathologyImmunotherapyStromal-derived Interleukin 6	2019	194
Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer Kristiaan Lenos, Daniël M. Miedema, Sophie C. Lodestijn, Nature Cell Biology Tumor BiologyTumour ExpansionMedicineStem Cell MobilizationStem Cells	2018	165
ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer Praneeth R. Kuninty, Ruchi Bansal, Susanna W.L. de Geus, Science Advances PathologyItga5 InhibitionImmunotherapeuticsCancer BiologyTumor Biology	2019	125
Molecular characterization of colorectal cancer related peritoneal metastatic disease Kristiaan Lenos, Sander Bach, Leandro F. Moreno, Nature Communications	2022	112

Page 1